KRBP SHAREHOLDER ALERT: Jakubowitz Law Reminds Kiromic Shareholders of a Lead Plaintiff Deadline of October 4, 2022PRNewsWire • 09/30/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Kiromic BioPharma Inc. - KRBPNewsfile Corp • 09/29/22
Kessler Topaz Meltzer & Check, LLP Reminds Investors of October 4, 2022 Deadline in Securities Fraud Class Action against Kiromic BioPharma, Inc. Investors and Urges Investors with Substantial Losses to Contact the FirmNewsfile Corp • 09/29/22
Kiromic Class Action: Levi & Korsinsky Reminds Kiromic BioPharma, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 4, 2022 - KRBPNewsfile Corp • 09/28/22
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Kiromic BioPharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2022 - (NASDAQ: KRBP)PRNewsWire • 09/28/22
Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the FirmNewsfile Corp • 09/25/22
KRBP DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important October 4, 2022 Deadline Reminder for Kiromic BioPharma, Inc.PRNewsWire • 09/24/22
ROSEN, Leading Investor Counsel, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important October 4 Deadline in Securities Class Action - KRBPNewsfile Corp • 09/23/22
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm's Attorneys Before Oct. 4th Deadline in Securities Class ActionNewsfile Corp • 09/21/22
Kiromic BioPharma, Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds KRBP Investors of Securities Fraud Class Action Lawsuit Filed On Their BehalfBusiness Wire • 09/21/22
KRBP INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Class ActionNewsfile Corp • 09/19/22
Attention Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Kiromic BioPharma, Inc. and Encourages Investors to Contact the FirmNewsfile Corp • 09/19/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Kiromic BioPharma Inc. -KRBPNewsfile Corp • 09/17/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 09/17/22
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPPRNewsWire • 09/16/22
ROSEN, A TOP RANKED LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPNewsfile Corp • 09/12/22
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/12/22
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against Kiromic BioPharma, Inc.Newsfile Corp • 09/10/22
KRBP CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Kiromic BioPharma (KRBP) Investors with Significant Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Class ActionNewsfile Corp • 09/09/22
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/09/22
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPPRNewsWire • 09/09/22
Important Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Kiromic BioPharma, Inc. Shareholders of Deadline in Securities Fraud Class Action LawsuitPRNewsWire • 09/07/22
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the FirmNewsfile Corp • 09/07/22
ROSEN, A LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - KRBPPRNewsWire • 09/06/22
